| Radiofrequency Ablation Growing In Popularity As A Treatment For ...
Millennium Research Group forecasts that radiofrequency ablation (RFA) procedures for cancer treatment will grow at almost 12% over the next five years in the US. According to Millennium Research Group's US Markets for Nonvascular Interventional Radiology Devices 2008 report, over 21,000 RFA procedures will be performed in 2007 on patients with liver, kidney, breast, lung, and metastatic bone cancers; by 2012, RFA procedures will reach over 36,000.
Physicians are opting for this surgery due to its minimally invasive nature and its ability to safely and precisely ablate small tumors. If the continued release of clinical evidence supports RFA treatment as a viable alternative to surgical resection, physician confidence in and the subsequent adoption of RFA devices take place.
"RFA can be used in cases where surgical resection poses too great of a risk to the patient," says Stephanie LaBelle, Analyst at MRG.
Greg Williams 'Hammers' The Ticket
On Friday, October 12, the most popular sports talk radio show in the history of Dallas prepared for a routine remote broadcast at Addison's Blackfin Pub. KTCK-1310 AM The Ticket afternoon co-host Mike Rhyner arrived on time. Longtime sidekick Greg Williams, however, was alarmingly tardy. Williams—"The Hammer" to a legion of loony fans that consistently makes the irreverent guy-talk station No. 1 in the market—finally appeared, albeit noticeably fidgety and audibly discombobulated. And then, just one segment into the four-hour show, he abruptly up and left. No one's sure where Williams had been. But now we know where he was headed—down a dangerous, dark detour toward self-destruction. One that, according to multiple sources, ultimately landed him in rehab for a cocaine problem.
Evelyn Pringle: Lilly Makes Billions Off Zyprexa While Approved for ...
For the first four years that Zyprexa was sold in the US, the promotion of the drug for any use other than adult schizophrenia was illegal. When the FDA approves a drug for a specific use, it can only be marketed for that use. Eli Lilly gained approval for schizophrenia in 1996 and the drug was not approved to treat bipolar disorder until 2000. Zyprexa belongs to a class of drugs known as "atypical" antipsychotics, which arrived on the market in the US beginning in 1993. Other drugs in this class include Seroquel, sold by AstraZeneca, Risperdal marketed by Johnson & Johnson subsidiary Janssen, Geodon, sold by Pfizer, Abilify, from Bristol-Myers Squibb and Clozaril manufactured by Novartis. Schizophrenia is considered the most severe of all mental illnesses and is said to occur in only about 1% of the population.
|
